Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by GlobeNewswire
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
99
100
Next >
Immatics Announces Third Quarter 2026 Financial Results and Business Update
November 10, 2026
From
https://immatics.com/
Via
GlobeNewswire
Tickers
IMTX
Gain Therapeutics Reports Financial Results for Third Quarter 2026 and Provides Corporate Update
November 10, 2026
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GANX
League of Live Stream Theater Uses LiveU Technology to Bring the Rent 30th Anniversary Concert to 70,000 Streaming Ticket Buyers Worldwide
November 10, 2026
From
LiveU Ltd.
Via
GlobeNewswire
WRAP Appoints Eric Bowen as Chief Operating Officer to Drive Execution and Scale Its Non-Lethal Response Business
November 10, 2026
From
Wrap Technologies, Inc.
Via
GlobeNewswire
Tickers
WRAP
Bitdeer Reports Unaudited Third Quarter 2026 Results: Record Revenue of US$320.7 Million; Adjusted EBITDA Up 173% to US$69.6 Million
November 10, 2026
From
Bitdeer Technologies Group
Via
GlobeNewswire
Tickers
BTDR
Xanadu and HyperLight Achieve Breakthrough of Nearly 3x Reduction in Optical Switch Loss, Accelerating Path to Commercial Photonic Quantum Systems
November 10, 2026
From
Xanadu Quantum Technologies Limited
Via
GlobeNewswire
Tickers
TSX:XNDU
XNDU
Olema Oncology Reports Third Quarter 2026 Financial and Operating Results
November 10, 2026
From
Olema Oncology
Via
GlobeNewswire
Tickers
OLMA
PridCor Therapeutics Announces First Patient Enrolled in Phase 2 SHIELD Study of a Combination Antiviral Regimen for Long COVID
November 10, 2026
From
PridCor Therapeutics, LLC
Via
GlobeNewswire
Sionna Therapeutics Reports Third Quarter 2026 Financial Results
November 10, 2026
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Tickers
SION
Soleo Health Selected as a Specialty Pharmacy Partner for Pasatru™, a New Treatment in Adults with Fibrodysplasia Ossificans Progressiva
November 10, 2026
From
Soleo Health Holdings, Inc.
Via
GlobeNewswire
Denodo Signs Strategic Collaboration Agreement with AWS to Accelerate Trusted Data Access for Agentic AI
November 10, 2026
From
Denodo Technologies Inc. (“Denodo”)
Via
GlobeNewswire
City Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of CITY-RBP4 for the Treatment of Stargardt Disease
November 10, 2026
From
City Therapeutics
Via
GlobeNewswire
Tickers
CTY
Palomino Laboratories to Participate in the Stifel Deep Tech Forum on December 7, 2026
November 10, 2026
From
Palomino Laboratories Inc
Via
GlobeNewswire
Tickers
PALX
Aurora Mobile's EngageLab Powers Real-Time Engagement for Purrrr’s Global IoT Cat Rescue Platform
November 10, 2026
From
Aurora Mobile Limited
Via
GlobeNewswire
Tickers
JG
Kailera Therapeutics to Present at ObesityWeek 2026
November 10, 2026
From
Kailera Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KLRA
etoro Reports Third Quarter 2026 Results
November 10, 2026
From
etoro Group Ltd.
Via
GlobeNewswire
Tickers
ETOR
Autolus Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates
November 10, 2026
From
Autolus Therapeutics plc
Via
GlobeNewswire
Tickers
AUTL
Hair Cuttery Announces North Carolina Expansion, Bringing 20+ Salons and 200+ Local Jobs by 2028
November 10, 2026
From
Hair Cuttery
Via
GlobeNewswire
Fate Therapeutics Presents New FT819 Data at ACR Convergence 2026 Highlighting Meaningful Clinical Responses in Lupus Without the Use of Conditioning Chemotherapy
November 10, 2026
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
PsiThera Closes $25 Million Financing to Advance Oral Therapeutics in Immunology
November 10, 2026
From
PsiThera
Via
GlobeNewswire
Harvard Bioscience Announces Third Quarter 2026 Financial Results
November 10, 2026
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Tickers
HBIO
Ovid Therapeutics Reports Business Updates and Third Quarter 2026 Financial Results
November 10, 2026
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Tickers
OVID
Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results
November 10, 2026
From
Cullinan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CGEM
Legend Biotech Reports Third Quarter 2026 Results and Recent Highlights
November 10, 2026
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Tickers
LEGN
PyroGenesis Announces Third Titanium Powder Contract with U.S. Applied Research Lab
November 10, 2026
From
PyroGenesis Inc.
Via
GlobeNewswire
Tickers
PYRGF
TSX:PYR
Talamore Mining Corp. Begins Trading on OTCQX Best Market
November 10, 2026
From
OTC Markets
Via
GlobeNewswire
Tickers
OTCM
TALMF
TSX:TALA
WEBTOON Entertainment Inc. to Participate in Upcoming Investor Conferences
November 10, 2026
From
WEBTOON Entertainment Inc.
Via
GlobeNewswire
Tickers
WBTN
Sono Group N.V. Reports Third Quarter 2026 Results: Swings to Net Income in First Full Quarter as Only a Bitcoin Treasury Company
November 10, 2026
From
Sono Group N.V.
Via
GlobeNewswire
Tickers
SEV
SEVCF
SSM
Vireo Growth Inc. Announces Third Quarter 2026 Results
November 10, 2026
From
Vireo Growth Inc.
Via
GlobeNewswire
Tickers
CSE:VREO
VREOD
VREOF
Bilt Selects Cerebras to Deliver Faster AI Experiences to More than Eight Million Members
November 10, 2026
From
Cerebras Systems Inc.
Via
GlobeNewswire
Tickers
CBRS
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.